Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design

BACKGROUND: Several studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO), but the question how to prevent further events in such patients is unresolved. Options include antithrombotic treatment with warfarin or antiplatelet agents or surgical or endova...

Descripción completa

Detalles Bibliográficos
Autores principales: Khattab, Ahmed A, Windecker, Stephan, Jüni, Peter, Hildick-Smith, David, Dudek, Dariusz, Andersen, Henning R, Ibrahim, Reda, Schuler, Gerhard, Walton, Antony S, Wahl, Andreas, Mattle, Heinrich P, Meier, Bernhard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058012/
https://www.ncbi.nlm.nih.gov/pubmed/21356042
http://dx.doi.org/10.1186/1745-6215-12-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058012/
https://www.ncbi.nlm.nih.gov/pubmed/21356042
http://dx.doi.org/10.1186/1745-6215-12-56

Ejemplares similares